Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Turns to China During Chemo Drug Crisis

Banned Chinese drugmaker allowed to ship API to help with shortage.

The FDA updated its ban against a Chinese drugmaker, because of a chemo drug shortage.

Zhejiang Hisun Pharmaceutical can now ship daunorubicin HCl, which is "used in the injected med DaunoXome, which in addition to Kaposi's sarcoma is used to treat specific types of leukemia and non-Hodgkin lymphoma," according to FiercePharma Manufacturing.

The FDA made the revision to their own ban because of a "critical drug shortage concern," the news outlet reported.

Last year the FDA banned 15 drugs from the same company.

"When FDA exempts certain drugs from an import alert due to shortage concerns, the agency also often requests the manufacturer to take certain measures to enhance quality oversight for products that are offered for entry into the United States," an FDA spokesman told Regulatory Focus, according to FiercePharma Manufacturing.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO